Schneider Patricia Jacqueline, Evaniew Nathan, McKay Paula, Ghert Michelle
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
Department of Surgery, McMaster University, 711 Concession Street, B3 169A, Hamilton, ON, L8V 5C2, Canada.
Clin Orthop Relat Res. 2017 Dec;475(12):3044-3055. doi: 10.1007/s11999-017-5482-7. Epub 2017 Aug 30.
Several challenges presently impede the conduct of prospective clinical studies in orthopaedic oncology, including limited financial resources to support their associated costs and inadequate patient volume at most single institutions. This study was conducted to prioritize research questions within the field so that the Musculoskeletal Tumor Society (MSTS), and other relevant professional societies, can direct the limited human and fiscal resources available to address the priorities that the stakeholders involved believe will have the most meaningful impact on orthopaedic oncology patient care.
QUESTIONS/PURPOSES: The purpose of this study was to use a formal consensus-based approach involving clinician-scientists and other stakeholders to identify the top priority research questions for future international prospective clinical studies in orthopaedic oncology.
A three-step modified Delphi process involving multiple stakeholder groups (including orthopaedic oncologists, research personnel, funding agency representation, and patient representation) was conducted. First, we sent an electronic questionnaire to all participants to solicit clinically relevant research questions (61 participants; 54% of the original 114 individuals invited to participate returned the questionnaires). Then, participants rated the candidate research questions using a 5-point Likert scale for five criteria (60 participants; 53% of the original group participated in this portion of the process). Research questions that met a priori consensus thresholds progressed for consideration to an in-person consensus meeting, which was attended by 44 participants (39% of the original group; 12 countries were represented at this meeting). After the consensus panel's discussion, members individually assigned scores to each question using a 9-point Likert scale. Research questions that met preset criteria advanced to final ranking, and panel members individually ranked their top three priority research questions, resulting in a final overall ranking of research priorities.
A total of 73 candidate research questions advanced to the consensus meeting. In the end, the consensus panel identified four research priorities: (1) Does less intensive surveillance of patients with sarcoma affect survival? (2) What are the survival outcomes over time for orthopaedic oncology implants? (3) Does resection versus stabilization improve oncologic and functional outcomes in oligometastatic bone disease? (4) What is the natural history of untreated fibromatosis?
The results of this study will assist in developing a long-term research strategy for the MSTS and, possibly, the orthopaedic oncology field as a whole. Furthermore, the results of this study can assist researchers in guiding their research efforts and in providing a justified rationale to funding agencies when requesting the resources necessary to support future collaborative research studies that address the identified orthopaedic oncology priorities.
目前,多项挑战阻碍了骨科肿瘤学前瞻性临床研究的开展,包括支持相关费用的资金有限,以及大多数单一机构的患者数量不足。开展本研究旨在对该领域的研究问题进行优先级排序,以便肌肉骨骼肿瘤学会(MSTS)及其他相关专业学会能够将有限的人力和财力资源用于解决相关利益者认为对骨科肿瘤患者护理最具意义影响的优先事项。
问题/目的:本研究的目的是采用一种基于正式共识的方法,让临床科学家和其他利益相关者参与,以确定未来骨科肿瘤学国际前瞻性临床研究的首要优先研究问题。
开展了一个涉及多个利益相关者群体(包括骨科肿瘤学家、研究人员、资助机构代表和患者代表)的三步改良德尔菲法。首先,我们向所有参与者发送电子问卷,以征集临床相关研究问题(61名参与者;受邀参与的114人中,54% 返回了问卷)。然后,参与者使用5点李克特量表对候选研究问题的五个标准进行评分(60名参与者;原始群体的53% 参与了该过程的这一部分)。达到先验共识阈值的研究问题进入面对面共识会议进行审议,44名参与者出席了该会议(原始群体的39%;有12个国家的代表参加了此次会议)。在共识小组讨论后,成员们使用9点李克特量表对每个问题进行单独评分。达到预设标准的研究问题进入最终排名,小组成员分别对他们的前三个优先研究问题进行排名,从而得出研究优先事项的最终总体排名。
共有73个候选研究问题进入共识会议。最终,共识小组确定了四个研究优先事项:(1)对肉瘤患者进行强度较低的监测是否会影响生存率?(2)骨科肿瘤植入物随时间推移的生存结果如何?(3)在寡转移性骨病中,切除与稳定化相比,是否能改善肿瘤学和功能结果?(4)未经治疗的纤维瘤病的自然病程是怎样的?
本研究结果将有助于为MSTS制定长期研究策略,甚至可能有助于整个骨科肿瘤学领域。此外,本研究结果可帮助研究人员指导其研究工作,并在向资助机构申请支持未来合作研究所需资源时,为解决已确定的骨科肿瘤优先事项提供合理依据。